However, our studies with human breast cancer cell lines revealed surprising results: non-CD44+/CD24- cells expressed much greater E-selectin ligand activity than CD44+/CD24- cells (Figure 3 and Table 1; Shirure et al., 2011, 2012; manuscript in preparation). The gene discussed is SELE; the disease is breast carcinoma.